Basel Medical Group Ltd (BMGL)

Basel Medical Group Cash Flow Statement

Financials in millions SGD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Net Income	0.43	2.07	1.78	1.98
Depreciation & Amortization	0.62	0.53	0.56	0.58
Asset Writedown & Restructuring Costs	-	-	0.05	-
Provision & Write-off of Bad Debts	-0.01	-0.01	0.16	0.03
Other Operating Activities	-0.5	-0.08	-0.23	0.13
Change in Accounts Receivable	-1.86	-0.42	0.54	0.01
Change in Inventory	0.01	0.02	-0.02	0
Change in Accounts Payable	-0.11	0.39	-0.22	0.06
Operating Cash Flow	-1.42	2.51	2.6	2.79
Operating Cash Flow Growth	-	-3.49%	-6.89%	-
Capital Expenditures	-0.02	-0.01	-0.01	-0.09
Investing Cash Flow	0.04	-0.01	-0.01	-0.09
Short-Term Debt Issued	-	1.42	-	-
Long-Term Debt Issued	-	-	-	1.03
Total Debt Issued	5.39	1.42	-	1.03
Short-Term Debt Repaid	-	-	-	-10.86
Long-Term Debt Repaid	-	-2.92	-2.94	-3.09
Total Debt Repaid	-6.78	-2.92	-2.94	-13.95
Net Debt Issued (Repaid)	-1.39	-1.5	-2.94	-12.92
Other Financing Activities	9.3	-0.27	0	-
Financing Cash Flow	7.9	-1.77	-2.94	-12.92
Net Cash Flow	6.5	0.73	-0.35	-10.22
Free Cash Flow	-1.44	2.5	2.59	2.7
Free Cash Flow Growth	-	-3.56%	-4.07%	-
Free Cash Flow Margin	-14.40%	24.84%	26.61%	25.37%
Free Cash Flow Per Share	-0.09	0.15	0.16	0.17
Cash Interest Paid	0.18	0.18	0.24	0.32
Cash Income Tax Paid	0.33	0.41	0.29	0.03
Levered Free Cash Flow	11.22	1.43	1.89	-
Unlevered Free Cash Flow	11.4	1.54	2.04	-
Change in Working Capital	-1.96	-0	0.29	0.08

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q